Company intelligence / Profile preview

BrainSonix

Los Angeles, California, United Statesbrainsonix.com ↗

Ownership: Private
Development stage: Other

Overview

BrainSonix has developed the BX Pulsar device based on LIFUP technology for non-invasive neuromodulation. Early clinical studies suggest safety and feasibility in modulating brain function for various neuropsychiatric conditions. The company markets its device primarily for research and investigational use; clinical efficacy data are still emerging.

Therapeutic areas: PsychiatryNeurologyEndocrinology
Modalities: Device (Low Intensity Focused Ultrasound Pulsation)Non-pharmacological therapy (Neuromodulation)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on BrainSonix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BrainSonix.

Explore the full profile